![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Prevalence of neurocognitive disorders in a well-treated and aging Swiss HIV Cohort
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle WA
Matthias Cavassini1*, Melanie Metral2*, Isabella Locatelli 3 , Peter Brugger4, Klemens Gutbrod5 , Andreas U. Monsch6,, Isaure Nadin7, Marc Schwind8, Riccardo Pignatti9, Renaud Du Pasquier2 , and the NAMACO study group**, a Swiss HIV Cohort Study 1 Service of Infectious Diseases, CHUV, 2 Service of Neurology, CHUV, 3 Institute of Social and Preventive Medicine, University of Lausanne, 4 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 5 Division of Neurology, University Hospital of Bern, 6 Memory Clinic, Felix Platter Hospital, Basel & Faculty of Psychology, University of Basel, 7 Service of Neurology, University Hospital of Geneva, 8 Neurology Clinic, St. Gallen, 9 Service of Neurology, EOC Lugano, Switzerland.
![0329171](../images/032917/032917-10/0329171.gif)
![0329172](../images/032917/032917-10/0329172.gif)
![0329173](../images/032917/032917-10/0329173.gif)
![0329174](../images/032917/032917-10/0329174.gif)
![0329175](../images/032917/032917-10/0329175.gif)
![0329176](../images/032917/032917-10/0329176.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|